With the philosophy of "Better science, Better lives," we envision becoming a world-class innovative biopharmaceutical company, and research and develop innovative drugs in the spirit of sustainable development. In addition, we follow the framework of Access to Medicine Index 2018 to formulate strategies and guidelines to take the enhancement of “accessibility,” “affordability” and “availability” as our core concept and commitment.



As a science-oriented company focusing on innovative biopharmaceuticals, we start from the UN Sustainable Development Goal (SDG) 3: health and well-being as the core.Our sustainable development goals also integrated the Sustainability Accounting Standard Board (SASB) standards for the biotechnology pharmaceuticals industry, GRI standards, the United Nations Global Covenant, and the Access to Medicine Index with our business operation and strategy. Therefore, we also promote the economy's ecological balance and sustainable development, society, and the environment. We will continue to build a new biopharmaceutical company that is innovative, trustworthy and respectable by patients and to maximize human health and well-being.